Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Masahiro Tanemura"'
Autor:
Hirotoshi Takayama, Shogo Kobayashi, Kunihito Gotoh, Kazuki Sasaki, Yoshifumi Iwagami, Daisaku Yamada, Yoshito Tomimaru, Hirofumi Akita, Tadafumi Asaoka, Takehiro Noda, Hiroshi Wada, Hidenori Takahashi, Masahiro Tanemura, Yuichiro Doki, Hidetoshi Eguchi
Publikováno v:
World Journal of Surgical Oncology, Vol 20, Iss 1, Pp 1-11 (2022)
Abstract Background SMAD4 is a key mediator of TGFβ signaling and one of the mutated genes in extrahepatic bile duct cancer (eBDC). It has been also reported that SMAD4 has dual functions, in carcinogenesis via silencing and in tumor invasion/metast
Externí odkaz:
https://doaj.org/article/1f4f796cb86d458990abd1c4001f81e2
Autor:
Daisaku Yamada, Shogo Kobayashi, Hidenori Takahashi, Hirofumi Akita, Terumasa Yamada, Tadafumi Asaoka, Junzo Shimizu, Yutaka Takeda, Shigekazu Yokoyama, Masanori Tsujie, Akira Tomokuni, Masahiro Tanemura, Osakuni Morimoto, Masahiro Murakami, Yongkook Kim, Shin Nakahira, Naoki Hama, Keishi Sugimoto, Kazuhiko Hashimoto, Yuichiro Doki, Hidetoshi Eguchi
Publikováno v:
Trials, Vol 22, Iss 1, Pp 1-11 (2021)
Abstract Background Pancreatic ductal adenocarcinoma (PDAC) is a lethal disease, and multimodal strategies, such as surgery plus neoadjuvant chemotherapy (NAC)/adjuvant chemotherapy, have been attempted to improve survival in patients with localized
Externí odkaz:
https://doaj.org/article/cd82a2db33fd41feafeb4352383c0dcf
Autor:
Masahiro Tanemura, Masahiro Murakami, Hirofumi Yamamoto, Hidetoshi Eguchi, Shigeru Marubashi, Koji Umeshita, Hiroshi Wada, Hiroaki Nagano, Shogo Kobayashi, Masaki Mori, Takehiro Noda, Yutaka Takeda, Yuichiro Doki
Publikováno v:
BMC Cancer, Vol 9, Iss 1, p 361 (2009)
BMC Cancer
BMC Cancer
Background The combination therapy of interferon (IFN)-alpha and 5-fluorouracil (5-FU) improved the prognosis of the patients with hepatocellular carcinoma (HCC). To determine the molecular mechanisms of the anti-tumor and anti-angiogenic effects, we